Search

Your search keyword '"D. Gibellini"' showing total 77 results

Search Constraints

Start Over You searched for: Author "D. Gibellini" Remove constraint Author: "D. Gibellini" Topic hiv-1 Remove constraint Topic: hiv-1
77 results on '"D. Gibellini"'

Search Results

1. Preliminary Study on the Possibility to Detect Virus Nucleic Acids in Post-Mortem Blood Samples.

2. Immunovirological outcome and HIV-1 DNA decay in a small cohort of HIV-1-infected patients deintensificated from Abacavir/Lamivudine/Dolutegravir to Lamivudine plus Dolutegravir.

3. The traditional use of Vachellia nilotica for sexually transmitted diseases is substantiated by the antiviral activity of its bark extract against sexually transmitted viruses.

4. Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.

5. M48U1 and Tenofovir combination synergistically inhibits HIV infection in activated PBMCs and human cervicovaginal histocultures.

6. HIV-1 Env associates with HLA-C free-chains at the cell membrane modulating viral infectivity.

7. Impact of Different Antiretroviral Strategies on Total HIV-DNA Level in Virologically Suppressed HIV-1 Infected Patients.

8. Dolutegravir Monotherapy in HIV-Infected Naive Patients With <100,000 Copies/mL HIV RNA Load.

9. HIV-1 gp120 impairs the differentiation and survival of cord blood CD34+ HPCs induced to the erythroid lineage.

10. Durable viral suppression in an HIV-infected patient in the absence of antiretroviral therapy.

11. Thermosensitive and mucoadhesive pluronic-hydroxypropylmethylcellulose hydrogel containing the mini-CD4 M48U1 is a promising efficient barrier against HIV diffusion through macaque cervicovaginal mucus.

12. HIV-1 coreceptor usage in paired plasma RNA and proviral DNA from patients with acute and chronic infection never treated with antiretroviral therapy.

13. Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histocultures.

14. Prevalence of R5 strains in multi-treated HIV subjects and impact of new regimens including maraviroc in a selected group of patients with CCR5-tropic HIV-1 infection.

15. Recent and long-lasting infections: the need for avidity testing in HIV-1 infected subjects.

16. Analysis of the effects of HIV-1 Tat on the survival and differentiation of vessel wall-derived mesenchymal stem cells.

17. HIV-1 and recombinant gp120 affect the survival and differentiation of human vessel wall-derived mesenchymal stem cells.

18. HIV-1 Tat protein enhances RANKL/M-CSF-mediated osteoclast differentiation.

19. HIV-1 subtype C transmission network: the phylogenetic reconstruction strongly supports the epidemiological data.

20. HIV-1 DNA proviral load in treated and untreated HIV-1 seropositive patients.

21. HIV-1 and HCV detection in dried blood spots by SYBR Green multiplex real-time RT-PCR.

22. HIV-1 infection of a nurse from a newborn with an unknown HIV infection: a case report.

23. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation.

24. HIV-1 DNA load analysis in peripheral blood lymphocytes and monocytes from naïve and HAART-treated individuals.

25. Low avidity antibody: a reliable method to diagnose a recent HIV-1 infection.

26. RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV-1-positive men.

27. Genotypic resistance in plasma and peripheral blood lymphocytes in a group of naive HIV-1 patients.

28. Simultaneous detection of HCV and HIV-1 by SYBR Green real time multiplex RT-PCR technique in plasma samples.

29. Meaning of DNA detection during the follow-up of HIV-1 infected patients: a brief review.

30. Different patterns of HIV-1 DNA after therapy discontinuation.

31. Quantitative DNA proviral detection in HIV-1 patients treated with antiretroviral therapy.

32. HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: a potential molecular mechanism to escape TRAIL cytotoxicity.

33. HIV-1 tat protein and cell proliferation and survival: a brief review.

34. Discordant resistance interpretations in multi-treated HIV-1 patients.

35. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) proviral DNA in peripheral blood mononuclear cells by SYBR green real-time PCR technique.

36. Quantitative detection of human immunodeficiency virus type 1 (HIV-1) viral load by SYBR green real-time RT-PCR technique in HIV-1 seropositive patients.

37. Drug failure during HIV-1 treatment. New perspectives in monitoring drug resistance.

38. Selective up-regulation of functional CXCR4 expression in erythroid cells by HIV-1 Tat protein.

39. Differentially expressed genes in HIV-1 tat-expressing CD4(+) T-cell line.

40. Development of drug resistance in HIV-1 patients receiving a combination of stavudine, lamivudine and efavirenz.

41. Inhibition of HIV-1 Tat activity correlates with down-regulation of bcl-2 and results in reduction of angiogenesis and oncogenicity.

42. Prevalence of multiple dideoxynucleoside analogue resistance (MddNR) in a cohort of Italian HIV-1 seropositive patients extensively treated with antiretroviral drugs.

43. Relationships between the presence of anti-Tat antibody, DNA and RNA viral load.

44. Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients.

45. Antibody to HIV-1 Tat protein, a key molecule in HIV-1 pathogenesis. A brief review.

46. HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand.

47. Analysis of HIV-1 drug resistant mutations by line probe assay and direct sequencing in a cohort of therapy naive HIV-1 infected Italian patients.

48. Extracellular HIV-1 Tat protein activates the transcriptional repressor inducible cAMP early repressor in both the Jurkat cell line and primary peripheral blood mononuclear cells.

49. HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells.

50. Human immunodeficiency virus type 1 Nef protein sensitizes CD4(+) T lymphoid cells to apoptosis via functional upregulation of the CD95/CD95 ligand pathway.

Catalog

Books, media, physical & digital resources